Alnylam Pharmaceuticals
ALNY
#606
Rank
C$47.13 B
Marketcap
$365.46
Share price
-1.49%
Change (1 day)
60.47%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company